Intervention Review

Atypical antipsychotics for aggression and psychosis in Alzheimer's disease

  1. Clive G Ballard1,*,
  2. Jonathan Waite2,
  3. Jacqueline Birks3

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 8 OCT 2008

Assessed as up-to-date: 21 FEB 2006

DOI: 10.1002/14651858.CD003476.pub2

Database Title

Additional Information

How to Cite

Ballard CG, Waite J, Birks J. Atypical antipsychotics for aggression and psychosis in Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD003476. DOI: 10.1002/14651858.CD003476.pub2.

Author Information

  1. 1

    Kings College London, The Wolfson Centre for Age-Related Diseases, London, UK

  2. 2

    The Courtyard, Old Age Psychiatary, Nottingham, UK

  3. 3

    University of Oxford, Centre for Statistics in Medicine, Oxford, UK

*Clive G Ballard, The Wolfson Centre for Age-Related Diseases, Kings College London, The Wolfson Wing, Hodgkin Building, Guy's Campus, London, SE1 1UL, UK. clive.ballard@kcl.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 OCT 2008

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (59K)Standard (419K)Full (1331K)

  1. Current Version

    Atypical antipsychotics for aggression and psychosis in Alzheimer's disease

    Clive G Ballard, Jonathan Waite and Jacqueline Birks

    Article first published online: 8 OCT 2008 | DOI: 10.1002/14651858.CD003476.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    The effectiveness of atypical antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease

    C Ballard, M Lana, T Waite, R Bullock and A Bayly

    Article first published online: 19 OCT 2005 | DOI: 10.1002/14651858.CD003476

View Full Article (HTML) Summary (59K)Standard (419K)Full (1331K)